Evaluating the Efficacy and Safety of Hemofence (Thorombin Cross-Linked Sodium Hyaluronate Gel Matrix) in Hemostasis for Intractable Exudative Bleeding in Spinal Surgery: A Multicenter, Randomized, Phase III Clinical Trial

Objective To demonstrate the noninferiority of the novel hemostatic agent, Hemofence (BMI Korea Co., Ltd., thrombin cross-linked sodium hyaluronate gel matrix) compared to the established agent, Floseal Hemostatic Matrix (Baxter, thrombin-gelatin matrix) in achieving hemostasis for spinal surgeries,...

Full beskrivning

Bibliografiska uppgifter

Huvudupphov:	Sungjae An, Woo-Keun Kwon, Il Choi, Jang-Bo Lee, Joohyun Kim, Junseok W. Hur
Materialtyp:	Artigo
Språk:	Inglês
Utgiven:	Korean Spinal Neurosurgery Society 2024-09-01
Serie:	Neurospine
Ämnen:	hemostasis hemofence floseal hyaluronic acid thrombin spin
Länkar:	http://e-neurospine.org/upload/pdf/ns-2448024-012.pdf
Taggar:	Lägg till en tagg Inga taggar, Lägg till första taggen!